Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales

International Journal of Drug Policy

Volumn 21, Issue 5, 2010, Pages 425-428

  Costenbader, Elizabeth C ^a   Zule, William A ^b   Coomes, Curtis C ^b  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b RTI INTERNATIONAL   (United States)

Author keywords

African Americans; Carrying syringes; Injecting drug users; Purchasing syringes

Indexed keywords

DIAMORPHINE;

ADULT; AFRICAN AMERICAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DRUG LEGISLATION; DRUG USE; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INJECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PHARMACY; PRIORITY JOURNAL; RACE DIFFERENCE; RISK REDUCTION; SYRINGE; SYRINGE EXCHANGE PROGRAM; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AFRICAN AMERICANS; COMMERCE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HIV INFECTIONS; HUMANS; LEGISLATION, PHARMACY; MALE; NEEDLE SHARING; NEEDLE-EXCHANGE PROGRAMS; NORTH CAROLINA; PHARMACIES; SUBSTANCE ABUSE, INTRAVENOUS; SYRINGES; YOUNG ADULT;

EID: 77955846888     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2009.12.006     Document Type: Article

References (29)

1. Burris S., Vernick J.S., Ditzler A., Strathdee S. The legality of selling or giving syringes to injection drug users. Journal of the American Pharmacists Association (Washington) 2002, 42(6 Suppl. 2):S13-S18.
2. Burris S., Strathdee S.A., Vernick J.S. Lethal injections: The law, science, and politics of syringe access for injection drug users. The University of San Francisco Law Review 2003, 37(4):813-885.
3. Carlson R.G., Wang J., Siegal H.A. An ethnographic approach to targeted sampling: Problems and solutions in AIDS prevention research among injection drug and crack-cocaine users. Human Organization 1994, 53:279-286.
4. CDC Syringe exchange programs-United States, 2005. MMWR Morbidity and Mortality Weekly Report 2007, 56(44):1164-1167.
5. Compton W.M., Cottler L.B., Decker S.H., Mager D., Stringfellow R. Legal needle buying in St. Louis. American Journal of Public Health 1992, 82(4):595-596.
6. Compton W.M., Horton J.C., Cottler L.B., Booth R., Leukefeld C.G., Singer M., et al. A multistate trial of pharmacy syringe purchase. Journal of Urban Health 2004, 81(4):661-670.
7. Darke S. Self-report among injecting drug users: A review. Drug and Alcohol Dependence 1998, 51(3):253-263. [discussion 267-258].
8. Friedman S.R., Perlis T., Des Jarlais D.C. Laws prohibiting over-the-counter syringe sales to injection drug users: Relations to population density, HIV prevalence, and HIV incidence. American Journal of Public Health 2001, 91(5):791-793.
9. Friedman S.R., Cooper H.L., Tempalski B., Keem M., Friedman R., Flom P.L., et al. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS 2006, 20(1):93-99.
10. Fuller C.M., Galea S., Blaney S., Ompad D.C., Deren S., Des Jarlais D., et al. Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Ethnicity and Disease 2004, 14(4):589-596.
11. Fuller C.M., Galea S., Caceres W., Blaney S., Sisco S., Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. American Journal of Public Health 2007, 97(1):117-124.
12. Macalino G.E., Celentano D.D., Latkin C., Strathdee S.A., Vlahov D. Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Education and Prevention 2002, 14(5):367-378.
13. McNeely J., Arnsten J.H., Gourevitch M.N. Sterile syringe access and disposal among injection drug users newly enrolled in methadone maintenance treatment: A cross-sectional survey. Harm Reduction Journal 2006, 3:8.
14. Needle R., Fisher D.G., Weatherbee N., Chitwood D., Brown B., Cesari H., et al. Reliability of self-reported HIV risk behaviors of drug users. Psychology of Addictive Behaviors 1995, 9:242-250.
15. North Carolina Administrative Code. (2007). Title 21, Occupational Licensing Boards and Commissions: Pharmacy. Section 1800-Prescriptions, 21 NCAC 46.1801, Right to refuse a prescription. Available at Accessed on 10 February, 2009. http://ncrules.state.nc.us/ncac/title%2021%20-20occupational%20licensing%20boards%20and%20commissions/chapter%2046%20-%20pharmacy/21%20ncac%2046%20.1801.pdf.
16. North Carolina General Statutes. (1994). G.S. § 90-113.22. Manufacture or delivery of drug paraphernalia. Available at Accessed on 10 February, 2009. http://www.ncleg.net/enactedlegislation/statutes/pdf/bysection/chapter_90/gs_90-113.23.pdf.
17. Reich W., Compton W.M., Horton J.C., Cottler L.B., Cunningham-Williams R.M., Booth R., et al. Pharmacist ambivalence about sale of syringes to injection drug users. Journal of the American Pharmacists Association (Washington) 2002, 42(6 Suppl. 2):S52-S57.
18. Simpson H.L. Injection drug users and pharmacists: A call for compassion, cooperation, and care. Journal of the American Pharmacists Association (Washington) 2002, 42(6 Suppl. 2):S10-S12.
19. Singer M., Baer H.A., Scott G., Horowitz S., Weinstein B. Pharmacy access to syringes among injecting drug users: Follow-up findings from Hartford, Connecticut. Public Health Report 1998, 113(June (Suppl. 1)):81-89.
20. Stimson G.V. AIDS and injecting drug use in the United Kingdom, 1987-1993: The policy response and the prevention of the epidemic. Social Science and Medicine 1995, 41(5):699-716.
21. Taussig J.A., Weinstein B., Burris S., Jones T.S. Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US. Aids 2000, 14(Suppl. 1):S47-S51.
22. The Legal of Prescribing and Dispensing Sterile Injection Equipment to IDUs to Prevent Disease Transmission. Available at Accessed on 5 December, 2009. http://www.temple.edu/lawschool/aidspolicy/apolicy.htm.
23. van Ameijden E.J., Coutinho R.A. Large decline in injecting drug use in Amsterdam, 1986-1998: Explanatory mechanisms and determinants of injecting transitions. Journal of Epidemiology and Community Health 2001, 55(5):356-363.
24. Wasley A., Miller J.T., Finelli L. Surveillance for acute viral hepatitis-United States, 2005. MMWR Surveillance Summaries 2007, 56(3):1-24.
25. Watters J.K., Biernacki P. Targeted sampling: Options for the study of hidden populations. Social Problems 1989, 36:416-430.
26. Weatherby N.L., Needle R., Cesari H., Booth R., McCoy C.B., Watters J.K., et al. Validity of self-reported drug use among injection drug users and crack cocaine users recruited through street outreach. Evaluation and Program Planning 1994, 17(4):347-355.
27. Wodak A. Lessons from the first international review of the evidence for needle syringe programs: The band still plays on. Substance Use and Misuse 2006, 41(6-7):837-839.
28. Zule W.A., Costenbader E.C., Meyer W.J., Wechsberg W.M. Methamphetamine use and risky sexual behaviors during heterosexual encounters. Sexually Transmitted Diseases 2007, 34(9):689-694.
29. Zule W.A., Costenbader E.C., Coomes C.M., Wechsberg W.M. Effects of an HCV risk reduction motivational intervention on alcohol use, injection and sexual risk behaviors. American Journal of Public Health 2009, 99(S1):S180-S186.